You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection

Join Daniel Swanson as he presents Building Flexibility for Multiple Cell Therapy Processes at the ISPE 2020 Biopharmaceutical Manufacturing Virtual Conference.

Many cell therapy firms have a diverse pipeline of promising drug candidates and are faced with the growing challenge of how to manufacture these drugs in a safe, timely, and cost-effective manner. Failed clinical trials leave abandoned assets behind, but manufacturing multiple products in the same facility can mitigate much of the associated risk costs.  To manufacture multiple cell therapy products safely, a deliberate strategy needs to be implemented from the inception of facility design. This topic addresses the cell therapy challenge of building a commercial facility for products that are still in clinical trials and will assess the best practices and case studies of building flexibility of multiple products in the same facility and weigh the benefits and cost of the flexibility.

Read more and register here: https://ispe.org/conferences/2020-ispe-biopharmaceutical-manufacturing-virtual-conference

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue